CClinicalTrials.gg
RecruitingNCT04861454Updated Nov 18, 2023

Brassiere Brow Suture and Internal Browpexy

An observational study in Eyelid Diseases, sponsored by Benha University. Recruiting at 1 site in United Arab Emirates. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-11-18.

Sponsored by Benha University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
30
Ages
18 Years and older
Sex
All
01

Study summary

Brow ptosis is a common problem. internal browbexy and brassier suture are common surgical approach

Read the detailed description

upper eye transcutaneous blepharoplasty then combined browbexy and brassier suture are done

02

Conditions studied

  • Eyelid Diseases

Browse trials for

Keywords

  • blepharoplasty
  • browbexy
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

At least 18 years with dermatochalasis

Inclusion criteria

  • brow ptosis and dermatochalasis

Exclusion criteria

Exclusion Criteria:

  • eyelid diseases and previous surgery
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
30 participants (estimated)
Patient registry
No

Groups and cohorts

  • surgical

    internal browbexy and brassier suture were done after blepharoplasty

05

What researchers measure

Primary outcomes

  1. global aesthetic scale

    calculate scale score from score 1 exceptional improvement to 5 worsening patient

    Time frame: 1 year

06

Study locations

1 of 1 sites recruiting
  • INMC
    Abu Dhabi, 46266, United Arab Emirates
    Recruiting
07

Registry details

Key details

Study ID
NCT04861454
Lead sponsor
Benha University
Responsible party
Tarek Roshdy mohamed Mahgoub ELhamaky (Associate Professor, Benha University) — Principal investigator
First posted
Apr 27, 2021
Start date
Jan 10, 2021
Primary completion
Jul 10, 2024 (estimated)
Completion
Jul 20, 2024 (estimated)
Last update
Nov 18, 2023

Study contacts

TAREK R ELHAMAKY, MD
Contact
dr_thamakyy@yahoo.com
503207889 ext. +971
TAREK ELHAMAKY
Contact
tarek elhamaky, MD
principal investigator · benha faculty of medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion